Medtronic’s Diabetes Spinoff Just Surged. What To Look For In Its Earnings.

Medtronic’s (MDT) diabetes spinoff, MiniMed (MMED), hit a record high Tuesday after the company hiked its full-year guidance on the back of a fiscal first-quarter sales beat. MiniMed sells a series of insulin pumps and continuous glucose monitors, or CGMs, for patients with diabetes. It spun off from Medtronic in March. For its first full quarter as a stand-alone company,…